As a China-based manufacturer and distributor, we understand regulatory documentation requirements, logistics coordination, and compliance expectations for peptide APIs
With our broad stock and personalized benefit, we're committed to assembly your skincare and wellness needs productively and viably
Medical-Grade GHK-Cu Therapy Administered via targeted injection or protocol-specific delivery for optimal cellular signaling
Protocol approach 2: gut-focused autoimmune support (BPC-157 plus KPV) Goal: Restore gut barrier integrity and reduce intestinal inflammation Components: BPC-157 : 200-300 mcg twice daily, orally or subcutaneously near the abdomen (promotes mucosal healing, angiogenesis) KPV: 200-500 mcg daily, orally (NF-kB inhibition, cytokine reduction, PepT1-mediated gut absorption) Rationale: For autoimmune conditions with significant gastrointestinal involvement, including IBD, celiac-associated inflammation, or any autoimmune condition complicated by leaky gut, this combination addresses both the physical barrier damage (BPC-157) and the inflammatory signaling (KPV)
